Role of IL-17 in gastrointestinal diseases caused by Helicobacter Pylori- infection

Bing-zheng SHEN,Jin-chun SONG,Yan PENG,Ling-li ZHANG,Fan ZHANG,Yan YU
DOI: https://doi.org/10.3969/j.issn.1003-6350.2016.01.035
2016-01-01
Abstract:Helicobacter pylori infection is an important factor which is related to gastritis, gastric ulcer, gastric cancer and other gastrointestinal diseases. In the process of infection, it can produce many cytokines. In recent years, many researches have proved that the interleukin-17 (IL-17) plays an important role in pathophysiology of infection and immune mediated gastrointestinal diseases. IL-17 increased in H. pylori infected patients with gastric mucosa. The activa-tion of MAPK/ERK 1/2 signaling pathway may lead to the expression of IL-8, which is a chemotactic factor of neutro-phils and promote inflammation. Regulatory T cells (Tregs) can suppress the inflammatory response. At present, the mechanism of H. pylori induced inflammation has not yet been fully understood, and host and pathogen can both pro-mote inflammation, such as cytotoxin associated gene A (cagA) and vac uolating cytotoxin A (vacA). IL-1β, IL-6, TNF-α, TGF-β1, IL-17, IL-18, IL-21 and IL-22 are related with gastric mucosal inflammation induced by H. pylori, but many details and different models of inflammatory response are still not clear. A large number of studies have shown that IL-17 has important function in the process of acute and chronic inflammation. In this paper, the relationship between IL-17 and gastrointestinal diseases, such as gastritis, gastric ulcer and gastric cancer, has been reviewed.
What problem does this paper attempt to address?